A Study to Evaluate the Efficacy and Safety of Pravastatin/Fenofibrate Complex in Patients With Combined Dyslipidemia With Adequately Controlled LDL-C But Inadequately Controlled Triglyceride Level by Atorvastatin Monotherapy

Trial Profile

A Study to Evaluate the Efficacy and Safety of Pravastatin/Fenofibrate Complex in Patients With Combined Dyslipidemia With Adequately Controlled LDL-C But Inadequately Controlled Triglyceride Level by Atorvastatin Monotherapy

Recruiting
Phase of Trial: Phase III

Latest Information Update: 30 Jun 2017

At a glance

  • Drugs Fenofibrate/pravastatin (Primary) ; Atorvastatin
  • Indications Dyslipidaemias
  • Focus Registrational; Therapeutic Use
  • Acronyms PRADA
  • Sponsors Yoo Young Pharmaceutical
  • Most Recent Events

    • 20 Jun 2017 Planned End Date changed from 1 Dec 2016 to 1 Dec 2017.
    • 20 Jun 2017 Planned primary completion date changed from 1 Dec 2016 to 1 Dec 2017.
    • 15 Nov 2016 Planned primary completion date changed from 1 May 2016 to 1 Dec 2016.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top